Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab혈액 악성 종양이있는 Covid-19 환자에서 특정 항체의 생산 및 지속성 : 리툭시 맙의 역할Observational Study Published on 2021-09-142022-09-01 Journal: Blood Cancer Journal [Category] SARS, 임상, 진단, 치료기술, 치료법, [키워드] anti-S antibodies B-cell lymphoma CLD Clinical management Control controls COVID-19 COVID-19 patient declining develop diffuse large B-cell lymphoma DLBCL effective follicular Follicular lymphoma Haematological cancer hematologic Hematologic malignancy hematological HM patient HM patients humoral immune response immune response lymphoma lymphoproliferative disorder MONITOR Multiple myeloma nasal swab nasal swabs nine nucleocapsid Patient PCR-negative persistence Production Prospective Study Protein Reinfection rituximab SARS-CoV-2 SARS-CoV-2 nucleocapsid seroconversion rate seroconversion rates Seropositivity specific antibody syndrome the SARS-CoV-2 Treatment vaccination was performed were measured within 6 months [DOI] 10.1038/s41408-021-00546-9 PMC 바로가기 [Article Type] Observational Study
Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the LiteratureCase Report Published on 2021-09-132024-09-02 Journal: Brain Sciences [Category] 대상포진, [키워드] Brain abscess Multiple myeloma Nocardia farcinica proteasome inhibitor [DOI] 10.3390/brainsci11091204 PMC 바로가기 [Article Type] Case Report
MM-219: Outcome of COVID-19 Among Patients with Multiple Myeloma at the Armenian Hematology CenterConference abstract Published on 2021-09-012022-10-05 Journal: Clinical lymphoma, myeloma & leukemia [Category] 유전자 메커니즘, [키워드] addition administration age Analysis Antibiotics association cardiovascular risk center Characteristics Chronic kidney disease clinical Cohort Comorbidities cough country COVID-19 COVID-19 infection Critical demonstrated Diabetes Mellitus diagnosed diagnosed with COVID-19 died Dyspnea elevated epidemiological Fever Hematological malignancy hematology high mortality Hospitalization Hospitalized hospitalized patients Hydroxychloroquine hyperlipidemia Hypogammaglobulinemia Hypoxemia Immunosuppression incidence Inflammatory marker inflammatory markers initial symptom Laboratory laboratory characteristics Lung disease lung infiltrate male Male sex mandatory mechanical ventilation median median age Mild MM Mortality Most patient Multiple Multiple myeloma multiple organ failure Myeloma obesity Patient patients performed Preliminary data reported required Result Retrospective study serological response severity significantly the disease viral infection [DOI] 10.1016/S2152-2650(21)01959-5 [Article Type] Conference abstract
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma다발성 골수종 환자에서 2회분의 COVID-19 RNA 백신 접종에 대한 고도로 가변적인 SARS-CoV-2 스파이크 항체 반응Comment Published on 2021-08-092022-09-12 Journal: Cancer cell [Category] MERS, SARS, 유전자 메커니즘, 진단, [키워드] Abstract Antibody Response COVID-19 dose hematology Multiple myeloma oncology Patient RNA SARS-CoV-2 SARS-CoV-2 spike vaccination Vaccine [DOI] 10.1016/j.ccell.2021.06.014 PMC 바로가기 [Article Type] Comment
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 TreatmentArticle Published on 2021-07-282022-10-31 Journal: Cancers [Category] COVID-19, [키워드] age Anti-SARS-CoV-2 antibody response anti-SARS-CoV-2 vaccination anti-SARS-CoV-2 vaccine anti-SARS-CoV-2 vaccines anti-SARS-CoV-2-antibody Antibody titer Antibody titers B lymphocyte booster vaccination CD19+ Cell clinical factor correlated count COVID-19 pandemic current therapy cut-off value disease dyscrasia Efficacy first dose first vaccination Hematological malignancies immunomodulatory drug Linear regression majority mRNA Multiple Multiple myeloma multivariable Myeloma Patient patients plasma positive receiving reduced respond poorly response SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccination SARS-CoV-2 vaccine significantly significantly higher simple single-center study Treatment Vaccines [DOI] 10.3390/cancers13153800 PMC 바로가기 [Article Type] Article
Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19Review Published on 2021-07-162022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] accelerate acting administration affected agent anti-SARS-CoV-2 anticipated Antiviral Antiviral agents Antiviral effect antiviral property aplidin B.1.1.7 variant clinical Clinical data clinical evidence Combination COVID-19 current database demonstrated Dexamethasone effective Efficacy Ex vivo hospital hospitalized COVID-19 patients hospitalized patients Host inhibiting interactions intravenous isoform knowledge lack lineages mechanism multicentre Multiple myeloma Patient Plitidepsin Population profile regimen Remdesivir safety profile SARS-CoV-2 Standard of care standard treatment suggested translation Treatment Trial viral load reduction Viral proteins [DOI] 10.3390/jpm11070668 PMC 바로가기 [Article Type] Review
Impact of nationwide lockdown on cancer care during COVID-19 pandemic: A retrospective analysis from western IndiaObservational Study Published on 2021-07-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] SARS, 임상, [키워드] Breast Cancer Care Chemotherapy Comorbidities concerning conducted Cooperative COVID-19 COVID-19 pandemic ECOG score functional group Healthcare system Hematological malignancy highlight hospital Immunotherapy Impact impacted include India leukemia lockdown lymphoma majority median age medical record Multiple myeloma observation Oncologists Other parameters Patient patients Patients with cancer reduced reported retrieved retrospective Retrospective analysis Telemedicine therapy Transport Treatment [DOI] 10.1016/j.dsx.2021.05.004 PMC 바로가기 [Article Type] Observational Study
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019Research Published on 2021-06-262024-09-02 Journal: BMC Cancer [Category] 대상포진, [키워드] anti-CD38 Cytotoxic therapy Infection Multiple myeloma proteasome inhibitors [DOI] 10.1186/s12885-021-08451-x PMC 바로가기 [Article Type] Research
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in ChinaOriginal Research Published on 2021-06-142024-09-02 Journal: Frontiers in Oncology [Category] 대상포진, [키워드] immunomodulators maintenance Multiple myeloma optimal maintenance duration proteasome inhibitors [DOI] 10.3389/fonc.2021.665217 PMC 바로가기 [Article Type] Original Research
Multiple myeloma remission following COVID-19: an observation in search of a mechanism (a case report)Case Report Published on 2021-06-102022-10-28 Journal: The Pan African Medical Journal [Category] COVID-19, MERS, [키워드] addition age Cancer Care Case report Cell Chemotherapy coronavirus Coronavirus disease 2019 COVID-19 dyscrasia Health hematologic Hematologic malignancy immunosuppressant agents implication increased risk individual malignancies management mechanism Multiple Multiple myeloma observation occurred pathogenesis of COVID-19 Patient patient with COVID-19 patients plasma risk severe disease Treatment treatment regimen [DOI] 10.11604/pamj.2021.39.117.30000 PMC 바로가기 [Article Type] Case Report